Mortality Associated with Dextromethorphan Elizabeth H. Crane, Ph.D., M.P.H. CAPT Kathy Poneleit, M.P.H. Office of Applied Studies, SAMHSA American Public.

Slides:



Advertisements
Similar presentations
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research February 4, 2013 Vol.
Advertisements

309: An Overview of Commonly Abused Prescription Drugs.
Chapter Thirteen – Drug Analysis (Part I) FRSC 8104 Criminalistics II Professor Bensley.
A Growing Problem…. We Will Discuss Prescription vs. OTC medications Alarming trends Myths about prescription drug abuse Specific medications of abuse.
Delay from Testing HIV Positive until First HIV Care for Drug Users: Adverse Consequences and Possible Solutions Barbara J Turner MD, MSEd* John Fleishman.
Prevalence and Patterns of Nonmedical Use of OxyContin ® and Other Pain Relievers Joe Gfroerer Office of Applied Studies Substance Abuse and Mental Health.
Monitoring drug related overdose and mortality in Europe Dr. Eva Keller.
OVERDOSE SOLUTIONS 2013 OVERDOSE DATA FOR ALLEGHENY COUNTY Jennifer Janssen Manager Toxicology Laboratory Allegheny County Office of the Medical Examiner.
Findings from the Drug Abuse Warning Network Narcotic Analgesics Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies, Substance Abuse and Mental Health.
Jane Ungemack, DrPH University of Connecticut Health Center Governor’s Prevention Initiative for Youth Evaluation Team Needs Assessment Training Session.
TM Centers for Disease Control and Prevention National Center for Injury Prevention and Control Centers for Disease Control and Prevention National Center.
Heroin overdose: Myths, facts and intervention
National Overdose Deaths Number of Deaths from Prescription Drugs.
Drug Trends in Washington State & King County Caleb J. Banta-Green MPH MSW Alcohol & Drug Abuse Institute University of Washington
Prescription Drug Abuse and Misuse in the Elderly Thomas L. Patterson, Ph.D. Support for this work: NIMH Center Grants P30 MH49693 and MH45131, and by.
Epidemiology of Benzodiazepine Prescribing and Use Gerry & Marci’s Story 4 nd Annual Benzodiazepine Conference Portland, Maine 2006.
OCME Forensic Trends in Virginia
Prescription Opioid Use and Opioid-Related Overdose Death — TN, 2009–2010 Jane A.G. Baumblatt, MD Centers for Disease Control and Prevention Epidemic Intelligence.
1 Adolescent Mental Health: Key Data Indicators Gwendolyn J. Adam, Ph.D., L.C.S.W. Assistant Professor - Department of Pediatrics Section of Adolescent.
The South Florida Report January 2013 National Institute on Drug Abuse Community Epidemiology Work Group James N. Hall Report # 56 Center for Applied Research.
Joint NDAC/PAC meeting October 18, 2007 OTC Cold and Cough Products: Use in Children Advisory Committee Meeting October 18, 2007 Joel Schiffenbauer, MD.
NAPHSIS Annual Meeting 2014Slide 1 NAPHSIS ANNUAL MEETING | Seattle | June 8-11, 2014 VITAL RECORDS: A CULTURE OF QUALITY Washington State’s approach to.
1 National Estimates from the Drug Abuse Warning Network CAPT Kathy Poneleit United States Public Health Service Office of Applied Studies Substance Abuse.
Summary of Drug Abuse “Rates” in the United States: Focus on Morphine Catherine Dormitzer, PhD, MPH Division of Epidemiology Office of Surveillance and.
Unintentional Poisoning. Injury Facts  Unintentional Poisoning.
Prescription Drug Abuse & Suicide SAVING GENERATION RX: PREVENTING PRESCRIPTION DRUG ABUSE IN EAST TENNESSEE SEPTEMBER 19 TH, 2014 SAMANTHA NADLER, B.S.
DSaRM Advisory Committee May 18, 2005 Active Surveillance for Drug Safety Signals: Past, Present, and Future Mary Willy, Ph.D. Division of Drug Risk Evaluation.
March 2004 Prescription Drug Abuse in the United States.
CESAR FAX U n i v e r s i t y o f M a r y l a n d, C o l l e g e P a r k A Weekly FAX from the Center for Substance Abuse Research Sales data from the.
From the Monitoring the Future Study Report: The University of Michigan 2012.
Utah Emergency Medical Service Discharges Attributed to Opiate Use For Record Years
Injury Surveillance Activities of the National Center for Injury Prevention and Control Data Issues Lee Annest, Ph.D. Director, Office of Statistics and.
Broward County Report Substance Abuse Issues and Trends – Winter 2013 James N. Hall.
Drug and Alcohol Statistics Is this a problem???.
Copyright Alcohol Medical Scholars Program1 Medical Consequences of Alcohol and Drug Use Disorders Eric B. Raimo, M.D.
Terms & Definitions Samhsa’s Co-Occurring Center for Excellence COCE.
USE AND ABUSE PRESCRIPTION, NON- PRESCRIPTION, AND ILLEGAL DRUGS.
The NSDUH Report: National Survey on Drug Use and Health NSDUH Report Sept. 16, 2005 SAMHSA Office of Applied Studies NSDUH National Survey on.
Lifetime prevalence of Tobacco use, per age cohort in the United States (1997) and the Netherlands (1997) Source: Office of Applied Studies, SAMSHSA, National.
1 Findings from the Drug Abuse Warning Network Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies Substance Abuse and Mental Health Services Administration.
Suicide and Mental Health in Virginia: Marc Leslie Virginia Violent Death Reporting System Office of the Chief Medical Examiner Virginia Department.
SOURCE: Treatment Episode Data Set (TEDS) 2005SOURCE: Treatment Episode Data Set (TEDS) 2005 Admissions to Substance Abuse Treatment for the Abuse of Opioid.
Is It Medicine or Is it Candy? Catherine M. Tom, PharmD Assistant Professor of Pharmacy Practice Arnold & Marie Schwartz College of Pharmacy and Health.
2008 Update Presented by: Erin Johnson, MPH June, health.utah.gov/prescription.
Table 1. Prediction model for maximum daily dose of buprenorphine-naloxone in a 12-week treatment condition Baseline Predictors Maximum Daily Dose Standardized.
Medication Practices for the Elderly in U.S. Nursing Homes Lisa L. Dwyer, MPH Robin E. Remsburg, PhD, APRN, BC Division of Health Care Statistics National.
Substance Use among Older Adults (Age 50+): Current Prevalence and Future Expectations Presented by Joe Gfroerer U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES.
Drugs and Our Society Drug Taking Behavior Part 2.
Jennifer R. Havens, PhD, MPH Associate Professor
DEPARTMENT OF HEALTH AND HUMAN SERVICES Substance Abuse and Mental Health Services Administration OFFICE OF APPLIED STUDIES Treatment Episode Data Set.
1 Prescribing Pain Medication – Guidelines for the Emergency Department April 22, 2012 Jennifer Sabel, PhD.
1 National Estimates from the Drug Abuse Warning Network Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies Substance Abuse and Mental Health Services.
1 Did You Know 42% of US high school seniors use alcohol.
1 Psychology 320: Psychology of Gender and Sex Differences Lecture 54.
60 Ferebee Enterprises International, LLC Global Female Empowerment o/ c
November 5, 2007 APHA Annual Meeting Monitoring Policies at Work: Effects On Medication Use Jessica R. Jones, MPH Barbara A. Curbow, PhD University of.
OVER THE COUNTER DRUGS Drugs and Alcohol. What is a Drug? Definition: A substance that has a physiological effect when ingested or otherwise introduced.
DXM or Cough Medicine Abuse
Prescription Drug Monitoring Presented by: Len Abbott, Ph.D. Director Science and Technology Kathleen Valentine, General Manager PDM & Toxicology May 14,
Findings from the Drug Abuse Warning Network Immediate and Sustained Release Opioid Analgesics Judy K. Ball, Ph.D., M.P.A. Office of Applied Studies, Substance.
screening, brief intervention and referral to treatment
10th Annual Susan Li Conference
2017 New Mexico Substance Abuse Epidemiology Profile
Department of Health Management and Informatics
Bronx Community Health Dashboard: Drug Abuse and Opioids Created: 5/18/2017 Last Updated: 10/23/2017 See last slide for more information.
Module 1: Putting Drugs of Abuse and Clients in Perspective
Other Illicit Drug Use in Delaware: 2018 State Epidemiological Profile
Trends in Gabapentin Abuse Reported to Poison Centers,
2018 Delaware State Epidemiological Profile
Figure 1. National Drug Overdose Deaths Number Among All Ages, by Gender, Figure 1. National Drug Overdose Deaths—Number Among All Ages, by Gender,
Presentation transcript:

Mortality Associated with Dextromethorphan Elizabeth H. Crane, Ph.D., M.P.H. CAPT Kathy Poneleit, M.P.H. Office of Applied Studies, SAMHSA American Public Health Association November 6, 2007

Drug Abuse Warning Network  Public health surveillance system collecting data on morbidity and mortality associated with drugs –Emergency department visits –Deaths investigated by Medical Examiners/Coroners

DAWN Mortality Component – 2004  ME/Cs in 234 jurisdictions across U.S. –6 state-wide systems –46 metropolitan areas –Population of 93 million in participating jurisdictions –Approx. 32% of U.S. population covered  No national estimates  Not representative of U.S.

DAWN Case Criteria Was the death related to recent drug use?  Any age  Any drug  Any motive (not just drug “abuse”)

What Drugs Are Covered?  All types of drugs –Illicit drugs –Prescription and over-the-counter pharmaceuticals –Dietary supplements –Inhalants  Alcohol-in-combination (any age)  Alcohol alone (age < 21)

Dextromethorphan (“DXM”)  A cough suppressant in many OTC cough and cold medications  Overuse can cause dissociative effects similar to PCP and ketamine

Mortality Associated with DXM  In 2004, 164 deaths involving DXM reported to DAWN  Reported from 33 of the 234 jurisdictions  Manner of death –Accidental/natural (58%) –Could not be determined (26%) –Suicide (15%) –Homicide (1%)  Most died at home (63%) Source: Unpublished 2004 DAWN mortality data

DXM-Associated Deaths, Demographics Gender Source: Unpublished 2004 DAWN mortality data Race/ethnicity

DXM-Associated Deaths, Demographics Age Source: Unpublished 2004 DAWN mortality data Average age: 40

DXM, Opioids, Illicit Drugs – by Age Group Age Source: Unpublished 2004 DAWN mortality data

Identifying the Drugs Present  Most DXM cough/cold medications contain multiple ingredients –decongestants –antihistamines –analgesics  ME/Cs report individual ingredients because most come from toxicology  DAWN is rarely able to identify multi- ingredient products in these data

Polydrug Use in Deaths with DXM Source: Unpublished 2004 DAWN mortality data N=164 Average = 5.3 drugs

Drugs Reported with DXM – deaths Source: Unpublished 2004 DAWN mortality data

Types of Drugs Reported with DXM Drug CategoryDrug ReportsPercent of deaths Total Analgesic21975 Opioid* # Anti-anxiety/sedative/hypnotic14657 Benzodiazepine5425 Antidepressant10241 Illicit11052 Cocaine4330 Alcohol*3723 Antihistamine*3822 Source: Unpublished 2004 DAWN mortality data *Ingredient in cough/cold medication # Includes heroin

“Cause of Death”  ME/C determines –Immediate cause of death –Contributing cause(s) –Other significant conditions

Causes of Death Cause of DeathNumber of deaths Drug involvement154 Toxicity/overdose/acute intox.126 Polydrug/combined effects117 Drug abuse17 Adverse effects of drugs5 Illness/injury47 Other significant condition35 Source: Unpublished 2004 DAWN mortality data

Causes of Death – Drugs Cause of DeathNumber of deaths Drug named in COD98 Opioid * 63 DXM43 DXM sole cause3 Illicit drug34 Cocaine33 Alcohol16 Antidepressant16 Benzodiazepine11 *Includes heroin Source: Unpublished 2004 DAWN mortality data

 In 2004, 164 deaths involving DXM were reported to DAWN from 33 jurisdictions  Average age 40  Average of 5 drugs per death Summary – Characteristics

 Opioids most frequently cited as a cause of death (63 deaths)  DXM cited as a cause in 43 deaths –3 deaths attributed to DXM alone  Therefore cannot assume that DXM was the cause of all 164 deaths Summary – Cause of Death